PT  - JOURNAL ARTICLE
AU  - Kershaw V. Patel
AU  - Natalia De Albuquerque Rocha
AU  - Darren K. McGuire
TI  - Diabetes medications and cardiovascular outcome trials: Lessons learned
AID  - 10.3949/ccjm.84gr.17006
DP  - 2017 Oct 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 759--767
VI  - 84
IP  - 10
4099  - http://www.ccjm.org/content/84/10/759.short
4100  - http://www.ccjm.org/content/84/10/759.full
SO  - Cleve Clin J Med2017 Oct 01; 84
AB  - The US Food and Drug Administration’s current standards require that new diabetes medications demonstrate cardiovascular safety in large, long-term trials. New drugs that have been assessed in such trials are changing the management of type 2 diabetes.